"Frontage Clinical Services is an early stage clinical research organization offering a complete suite of services from study design to delivery of final report. We have over 20 years of experience in the execution of comprehensive Phase I-IIa studies. Our team has expertise with a broad range of study types and a wide variety of delivery systems Our Phase I facility is located in Secaucus, NJ, an ethnically diverse region, within close proximity to major medical centers, airports and transportation hubs. 36,000 sq. ft. modern clinic 160 beds with multiple units Secure limited-access Pharmacy Controlled substance management (Schedule 2-5 license) 2 full time Physicians serving as PIs Over 50% of staff with advanced degrees 0.25 miles to loc"

During the past decade, Frontage Clinical Services, Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 1 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frontage Clinical Services, Inc." #1 sponsor was "Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc." with 3 trials, followed by "Bayer" with 2 trials sponsored, "Shanghai Zhimeng Biopharma, Inc." with 2 trials sponsored, "7 Hills Pharma, LLC" with 1 trials sponsored and "Astex Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frontage Clinical Services, Inc." #1 collaborator was "Frontage Clinical Services, Inc." with 1 trials as a collaborator and "PXE International" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Frontage Clinical Services, Inc." are "Healthy" (7 trials), "Healthy Volunteers" (4 trials), "Clinical Pharmacology" (2 trials), "COVID 19" (1 trials) and "Cigarette Use, Electronic" (1 trials). Many other conditions were trialed in "Frontage Clinical Services, Inc." in a lesser frequency.

Most popular intervention types in "Frontage Clinical Services, Inc." are "Drug" (19 trials), "Other" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ciraparantag" (3 trials), "Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)" (2 trials), "Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)" (2 trials) and "7HP349 Food Effect" (1 trials). Other intervention names were less common.

The vast majority of trials in "Frontage Clinical Services, Inc." are 19 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Frontage Clinical Services, Inc.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Frontage Clinical Services, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Frontage Clinical Services, Inc., 13 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".